Publish in this journal
Journal Information
Vol. 68. Issue 2.
Pages 170-171 (February 2015)
Corrections
DOI: 10.1016/j.rec.2014.10.007
Full text access
Correction in article “Familial Left Ventricular Noncompaction Associated With a Novel Mutation in the Alphacardiac Actin Gene”, Rev Esp Cardiol. 2014;67:857-9
Correcci??n en el art??culo ??Miocardiopat??a no compactada familiar asociada con una mutaci??n nueva en el gen de la alfa actina cardiaca??, Rev Esp Cardiol. 2014;67:857-9
Visits
...
Related content
Rev Esp Cardiol. 2014;67:857-910.1016/j.rec.2014.05.015
María Rodríguez-Serrano, Diana Domingo, Begoña Igual, Ana Cano, Pilar Medina, Esther Zorio
Rev Esp Cardiol. 2015;68:166-710.1016/j.rec.2014.09.010
Josef Finsterer, Sinda Zarrouk-Mahjoub
This item has received
...
Visits
(Daily data update)
Article information
Full Text
Download PDF
Statistics
Tables (1)
Table. Results From the Clinical Family Evaluation
Full Text

In the article by Rodríguez-Serrano et al., “Familial Left Ventricular Noncompaction Associated With a Novel Mutation in the Alphacardiac Actin Gene”, published in Rev Esp Cardiol. 2014;67:857-9, the following errors were found:

Figure. In the last line of the family pedigree, where it says: “V: 1”, it should say: “IV:1”. The correct figure is:

Table. Row 7 has been duplicated by mistake. The characteristics of rows 4 and 6 (pedigree positions III:4 and III:6) have been switched. The correct table is:

Table.

Results From the Clinical Family Evaluation

Pedigree position  Sex/Age, y  Clinical history  ECG  Echocardiography  CMRI  Holter  Exercise testing  Genetics: heterozygous ACTC1I289T mutation 
II:3  F/59  Asymptomatic  Normal  Normal  —  —  —  Non carrier 
II:4  M/66  Dyspnea, NYHAclass I-II/IV  SR, first degree AV block, QS in the inferior leads  One year before this study, in another center: echocardiography within normal limitsAt the beginning of this study: LVNC, normal LV size; LVEF, 36%; moderately impaired RVEFAt follow-up: upper limit LV diameters with hypertrabeculation; LVEF, 25%; normal RVEF  LVNC; LVEF, 48%; intramyocardial LGE at the inferior wall and posterior septum  SR, unremarkable isolated ventricular ectopies, unremarkable atrial ectopies in isolation, couplets and salvoes  Normal  Carrier 
III:2  F/33  Asymptomatic  Normal  Normal  —  —  —  Non carrier 
III:4  M/31  Dysnea, NYHA class II/IV  SR, nonspecific ventricular activation delay  LVNC; spheric-shaped dilated LV (65/52 mm); LVEF, 25%; restrictive filling pattern; severe mitral regurgitation; normal-sized RV with preserved RVEF  LVNC; dilated LV; LVEF, 27%; prolapse of posterior mitral left with severe mitral regurgitation.  SR; scarce atrial ectopies in couplets and salvoes; ventricular ectopies in isolation (1908); couplets (43), and one salvoe (5 beats)  Ventricular ectopies and 1 nonsustained ventricular tachycardia (3 beats) at peak exercise  Carrier 
III:5  M/37  Asymptomatic  Normal  Normal  —  —  —  Non carrier 
III:6  F/32  Previous clinical history: OS-ASD repaired at 10 years of age; one miscarriage (hydrops)At follow-up: Dyspnea class I-II/IV NYHA  Normal  Three years before this study, in another center: echocardiography within normal limitsAt the beginning of this study: normal LV size; LVEF, 53%; apical and septal hypertrabeculation, restrictive filling pattern normal sized RV with mildly impaired RVEFAt 1-year follow-up: upper limit LV diameters (51/43 mm); LVEF, 36%; restrictive filling pattern; apical hypertrabeculation not fullfilling criteria for LVNC; moderate tricuspid regurgitation without pulmonary hypertension. upper limit RV diameters with mildly impaired RVEFAt 2-year follow-up: improvement of LVEF and RVEF  Three years before this study, in another center: hypertrabeculation in lateral and inferolateral regions; normal sized LV; LVEF, 51%At the beginning of this study: LVNC more prominent at the anterolateral and inferolateral wall; dilated LV; LVEF, 55%; RVEF, 46%; subepicardial LGE at the inferior and lateral walls; akinetic biventricular apical segments  SR, isolated rare atrial and ventricular ectopies  Normal  Carrier 
IV:1  F/3  Heart transplantation at 9 months of age because of refractory heart failure; no further clinical events  SR at 150 bpm; left atrial and LV hypertrophy and inespecific alteration in the ventricular repolarization  Before heart transplantation:dilated LV (36/27 mm) and LVEF, 46%; restrictive filling pattern; severe-moderate mitral and tricuspid regurgitation; moderate pulmonary hypertension; OS-ASD, 5 mmAt heart transplantation:LV hypertrabeculation  —  —  —  Carrier 

ACTC1, alpha-cardiac actin gene; AVB: atrioventricular block; CMRI, cardiac magnetic resonance imaging; ECG, electrocardiogram; F, female; LGE, late gadolinium enhancement; LV, left ventricle; LVEF, left ventricular ejection fraction; LVNC, left ventricular noncompaction; M, male; MI, myocardial infarction; NE, not evaluated; NYHA, New York Heart Association; OS-ASD, ostium secundum atrioseptal defect; RV, right ventricle; RVEF, right ventricular ejection fraction; SR: sinus rhythm.

These corrections were made in the electronic version of the article on 5 November 2014.

Copyright © 2014. Sociedad Española de Cardiología
Idiomas
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.